Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAI...

Por Devlin, Nancy, Herdman, Michael, Pavesi, Marco, Phung, De, Naidoo, Shevani, Beer, Tomasz M., Tombal, Bertrand, Loriot, Yohann, Ivanescu, Cristina, Parli, Teresa, Balk, Mark, Holmstrom, Stefan
Publicado no Health Qual Life Outcomes (2017)

Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer: The PREVAIL Randomized Clinical Trial

Por Rathkopf, Dana E., Beer, Tomasz M., Loriot, Yohann, Higano, Celestia S., Armstrong, Andrew J., Sternberg, Cora N., de Bono, Johann S., Tombal, Bertrand, Parli, Teresa, Bhattacharya, Suman, Phung, De, Krivoshik, Andrew, Scher, Howard I., Morris, Michael J.
Publicado no JAMA Oncol (2018)

Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

Por Beer, Tomasz M., Armstrong, Andrew J., Rathkopf, Dana, Loriot, Yohann, Sternberg, Cora N., Higano, Celestia S., Iversen, Peter, Evans, Christopher P., Kim, Choung-Soo, Kimura, Go, Miller, Kurt, Saad, Fred, Bjartell, Anders S., Borre, Michael, Mulders, Peter, Tammela, Teuvo L., Parli, Teresa, Sari, Suha, van Os, Steve, Theeuwes, Ad, Tombal, Bertrand
Publicado no Eur Urol (2016)